Serial volumetric MRI in Parkinsonian disorders
Identifieur interne : 002921 ( Main/Merge ); précédent : 002920; suivant : 002922Serial volumetric MRI in Parkinsonian disorders
Auteurs : Edward J. Wild [Royaume-Uni] ; Nick C. Fox [Royaume-Uni]Source :
- Movement Disorders [ 0885-3185 ] ; 2009.
English descriptors
- KwdEn :
- Disease Progression, Humans, Lewy Body Disease (pathology), Magnetic Resonance Imaging (methods), Multiple System Atrophy (pathology), Parkinson Disease (diagnosis), Parkinson Disease (pathology), Supranuclear Palsy, Progressive (pathology), dementia with lewy bodies, magnetic resonance imaging, multiple system atrophy, parkinson's disease, progressive supranuclear palsy.
- MESH :
- diagnosis : Parkinson Disease.
- methods : Magnetic Resonance Imaging.
- pathology : Lewy Body Disease, Multiple System Atrophy, Parkinson Disease, Supranuclear Palsy, Progressive.
- Disease Progression, Humans.
Abstract
Tracking progression in neurodegenerative diseases is hampered by the limitations of the clinical rating scales, which are seldom linear, suffer from floor and ceiling effects, lack the ability to distinguish symptomatic change from disease modification, and are limited by imperfect intra‐ and inter‐rater reliability. The promise of an era of neuroprotective therapies renders urgent the search for reliable measures of progression. Biomarkers have the potential to enhance several aspects of both therapeutic trials and clinical practice. MRI‐based measures of cerebral volume can provide a surrogate for neuronal loss and several techniques have been applied to elucidate disease processes, aid diagnosis, and enable monitoring of progression in a variety of Parkinsonian disorders, including Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, progressive supranuclear palsy and Huntington's disease. We review the approaches to, and findings revealed by, serial volumetric MRI in these disorders. © 2009 Movement Disorder Society
Url:
DOI: 10.1002/mds.22500
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001792
- to stream Istex, to step Curation: 001792
- to stream Istex, to step Checkpoint: 000C62
- to stream PubMed, to step Corpus: 001B26
- to stream PubMed, to step Curation: 001B26
- to stream PubMed, to step Checkpoint: 001B74
- to stream Ncbi, to step Merge: 002857
- to stream Ncbi, to step Curation: 002857
- to stream Ncbi, to step Checkpoint: 002857
Links to Exploration step
ISTEX:8D31798F89627389ED9EE4A060C8AEC61BF31A56Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Serial volumetric MRI in Parkinsonian disorders</title>
<author><name sortKey="Wild, Edward J" sort="Wild, Edward J" uniqKey="Wild E" first="Edward J." last="Wild">Edward J. Wild</name>
</author>
<author><name sortKey="Fox, Nick C" sort="Fox, Nick C" uniqKey="Fox N" first="Nick C." last="Fox">Nick C. Fox</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:8D31798F89627389ED9EE4A060C8AEC61BF31A56</idno>
<date when="2009" year="2009">2009</date>
<idno type="doi">10.1002/mds.22500</idno>
<idno type="url">https://api.istex.fr/document/8D31798F89627389ED9EE4A060C8AEC61BF31A56/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001792</idno>
<idno type="wicri:Area/Istex/Curation">001792</idno>
<idno type="wicri:Area/Istex/Checkpoint">000C62</idno>
<idno type="wicri:doubleKey">0885-3185:2009:Wild E:serial:volumetric:mri</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:19877198</idno>
<idno type="wicri:Area/PubMed/Corpus">001B26</idno>
<idno type="wicri:Area/PubMed/Curation">001B26</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001B74</idno>
<idno type="wicri:Area/Ncbi/Merge">002857</idno>
<idno type="wicri:Area/Ncbi/Curation">002857</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002857</idno>
<idno type="wicri:Area/Main/Merge">002921</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Serial volumetric MRI in Parkinsonian disorders</title>
<author><name sortKey="Wild, Edward J" sort="Wild, Edward J" uniqKey="Wild E" first="Edward J." last="Wild">Edward J. Wild</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology/National Hospital for Neurology and Neurosurgery, Queen Square, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fox, Nick C" sort="Fox, Nick C" uniqKey="Fox N" first="Nick C." last="Fox">Nick C. Fox</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology/National Hospital for Neurology and Neurosurgery, Queen Square, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2009">2009</date>
<biblScope unit="vol">24</biblScope>
<biblScope unit="issue">S2</biblScope>
<biblScope unit="page" from="S691">S691</biblScope>
<biblScope unit="page" to="S698">S698</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">8D31798F89627389ED9EE4A060C8AEC61BF31A56</idno>
<idno type="DOI">10.1002/mds.22500</idno>
<idno type="ArticleID">MDS22500</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Disease Progression</term>
<term>Humans</term>
<term>Lewy Body Disease (pathology)</term>
<term>Magnetic Resonance Imaging (methods)</term>
<term>Multiple System Atrophy (pathology)</term>
<term>Parkinson Disease (diagnosis)</term>
<term>Parkinson Disease (pathology)</term>
<term>Supranuclear Palsy, Progressive (pathology)</term>
<term>dementia with lewy bodies</term>
<term>magnetic resonance imaging</term>
<term>multiple system atrophy</term>
<term>parkinson's disease</term>
<term>progressive supranuclear palsy</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Magnetic Resonance Imaging</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Lewy Body Disease</term>
<term>Multiple System Atrophy</term>
<term>Parkinson Disease</term>
<term>Supranuclear Palsy, Progressive</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Disease Progression</term>
<term>Humans</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Tracking progression in neurodegenerative diseases is hampered by the limitations of the clinical rating scales, which are seldom linear, suffer from floor and ceiling effects, lack the ability to distinguish symptomatic change from disease modification, and are limited by imperfect intra‐ and inter‐rater reliability. The promise of an era of neuroprotective therapies renders urgent the search for reliable measures of progression. Biomarkers have the potential to enhance several aspects of both therapeutic trials and clinical practice. MRI‐based measures of cerebral volume can provide a surrogate for neuronal loss and several techniques have been applied to elucidate disease processes, aid diagnosis, and enable monitoring of progression in a variety of Parkinsonian disorders, including Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, progressive supranuclear palsy and Huntington's disease. We review the approaches to, and findings revealed by, serial volumetric MRI in these disorders. © 2009 Movement Disorder Society</div>
</front>
</TEI>
<double doi="10.1002/mds.22500"><ISTEX><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Serial volumetric MRI in Parkinsonian disorders</title>
<author><name sortKey="Wild, Edward J" sort="Wild, Edward J" uniqKey="Wild E" first="Edward J." last="Wild">Edward J. Wild</name>
</author>
<author><name sortKey="Fox, Nick C" sort="Fox, Nick C" uniqKey="Fox N" first="Nick C." last="Fox">Nick C. Fox</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:8D31798F89627389ED9EE4A060C8AEC61BF31A56</idno>
<date when="2009" year="2009">2009</date>
<idno type="doi">10.1002/mds.22500</idno>
<idno type="url">https://api.istex.fr/document/8D31798F89627389ED9EE4A060C8AEC61BF31A56/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001792</idno>
<idno type="wicri:Area/Istex/Curation">001792</idno>
<idno type="wicri:Area/Istex/Checkpoint">000C62</idno>
<idno type="wicri:doubleKey">0885-3185:2009:Wild E:serial:volumetric:mri</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Serial volumetric MRI in Parkinsonian disorders</title>
<author><name sortKey="Wild, Edward J" sort="Wild, Edward J" uniqKey="Wild E" first="Edward J." last="Wild">Edward J. Wild</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology/National Hospital for Neurology and Neurosurgery, Queen Square, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fox, Nick C" sort="Fox, Nick C" uniqKey="Fox N" first="Nick C." last="Fox">Nick C. Fox</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology/National Hospital for Neurology and Neurosurgery, Queen Square, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2009">2009</date>
<biblScope unit="vol">24</biblScope>
<biblScope unit="issue">S2</biblScope>
<biblScope unit="page" from="S691">S691</biblScope>
<biblScope unit="page" to="S698">S698</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">8D31798F89627389ED9EE4A060C8AEC61BF31A56</idno>
<idno type="DOI">10.1002/mds.22500</idno>
<idno type="ArticleID">MDS22500</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>dementia with lewy bodies</term>
<term>magnetic resonance imaging</term>
<term>multiple system atrophy</term>
<term>parkinson's disease</term>
<term>progressive supranuclear palsy</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Tracking progression in neurodegenerative diseases is hampered by the limitations of the clinical rating scales, which are seldom linear, suffer from floor and ceiling effects, lack the ability to distinguish symptomatic change from disease modification, and are limited by imperfect intra‐ and inter‐rater reliability. The promise of an era of neuroprotective therapies renders urgent the search for reliable measures of progression. Biomarkers have the potential to enhance several aspects of both therapeutic trials and clinical practice. MRI‐based measures of cerebral volume can provide a surrogate for neuronal loss and several techniques have been applied to elucidate disease processes, aid diagnosis, and enable monitoring of progression in a variety of Parkinsonian disorders, including Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, progressive supranuclear palsy and Huntington's disease. We review the approaches to, and findings revealed by, serial volumetric MRI in these disorders. © 2009 Movement Disorder Society</div>
</front>
</TEI>
</ISTEX>
<PubMed><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Serial volumetric MRI in Parkinsonian disorders.</title>
<author><name sortKey="Wild, Edward J" sort="Wild, Edward J" uniqKey="Wild E" first="Edward J" last="Wild">Edward J. Wild</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology/National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology/National Hospital for Neurology and Neurosurgery, Queen Square, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fox, Nick C" sort="Fox, Nick C" uniqKey="Fox N" first="Nick C" last="Fox">Nick C. Fox</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2009">2009</date>
<idno type="doi">10.1002/mds.22500</idno>
<idno type="RBID">pubmed:19877198</idno>
<idno type="pmid">19877198</idno>
<idno type="wicri:Area/PubMed/Corpus">001B26</idno>
<idno type="wicri:Area/PubMed/Curation">001B26</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001B74</idno>
<idno type="wicri:Area/Ncbi/Merge">002857</idno>
<idno type="wicri:Area/Ncbi/Curation">002857</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002857</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Serial volumetric MRI in Parkinsonian disorders.</title>
<author><name sortKey="Wild, Edward J" sort="Wild, Edward J" uniqKey="Wild E" first="Edward J" last="Wild">Edward J. Wild</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology/National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology/National Hospital for Neurology and Neurosurgery, Queen Square, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fox, Nick C" sort="Fox, Nick C" uniqKey="Fox N" first="Nick C" last="Fox">Nick C. Fox</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2009" type="published">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Disease Progression</term>
<term>Humans</term>
<term>Lewy Body Disease (pathology)</term>
<term>Magnetic Resonance Imaging (methods)</term>
<term>Multiple System Atrophy (pathology)</term>
<term>Parkinson Disease (diagnosis)</term>
<term>Parkinson Disease (pathology)</term>
<term>Supranuclear Palsy, Progressive (pathology)</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Magnetic Resonance Imaging</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Lewy Body Disease</term>
<term>Multiple System Atrophy</term>
<term>Parkinson Disease</term>
<term>Supranuclear Palsy, Progressive</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Disease Progression</term>
<term>Humans</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Tracking progression in neurodegenerative diseases is hampered by the limitations of the clinical rating scales, which are seldom linear, suffer from floor and ceiling effects, lack the ability to distinguish symptomatic change from disease modification, and are limited by imperfect intra- and inter-rater reliability. The promise of an era of neuroprotective therapies renders urgent the search for reliable measures of progression. Biomarkers have the potential to enhance several aspects of both therapeutic trials and clinical practice. MRI-based measures of cerebral volume can provide a surrogate for neuronal loss and several techniques have been applied to elucidate disease processes, aid diagnosis, and enable monitoring of progression in a variety of Parkinsonian disorders, including Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, progressive supranuclear palsy and Huntington's disease. We review the approaches to, and findings revealed by, serial volumetric MRI in these disorders.</div>
</front>
</TEI>
</PubMed>
</double>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002921 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 002921 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Merge |type= RBID |clé= ISTEX:8D31798F89627389ED9EE4A060C8AEC61BF31A56 |texte= Serial volumetric MRI in Parkinsonian disorders }}
![]() | This area was generated with Dilib version V0.6.23. | ![]() |